FA
BSX icon

Fagan Associates’s Boston Scientific BSX Stock Holding History

Fagan Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51,195
Closed -$2.31M – 106
2019
Q4 		$2.31M Buy
51,195
+3,130
+7% +$131K 0.75% 40
2019
Q3 		$1.96M Buy
48,065
+11,385
+31% +$482K 0.76% 42
2019
Q2 		$1.58M Buy
36,680
+9,420
+35% +$362K 0.64% 44
2019
Q1 		$1.05M Buy
+27,260
New +$1.04M 0.45% 57

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Fagan Associates's BSX Position: Q1 2020 in Review

Fagan Associates sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 51,195 shares — an estimated $2.31M sold.

Fagan Associates first reported a position in BSX in Q1 2019 and held it in 4 quarters. The position peaked at $2.31M in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Fagan Associates reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Fagan Associates sold 51,195 Boston Scientific shares in Q1 2020, an estimated $2.31M.
  • Fagan Associates first reported a position in Boston Scientific in Q1 2019 and held it in 4 quarters.
  • Fagan Associates's Boston Scientific position peaked at $2.31M in Q4 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Fagan Associates's 13F filing for Q1 2020, filed 5 May 2020.